We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA, Endo Pause Bulk Compounding Lawsuit Pending FDA Guidance
FDA, Endo Pause Bulk Compounding Lawsuit Pending FDA Guidance
The FDA filed a joint motion with Endo to pause the company’s lawsuit accusing the agency of breaking the law with its decree authorizing bulk compounding of drugs.